We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MOWI:EURONEXT OSLOMowi ASA Analysis

Data as of 2026-08-13 - not real-time

NOK 203.20

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind Mowi ASA is neutral at NOK 203.20, with no clear ordering between short and long averages. Across the trailing 30 sessions it gained 12.4%. With RSI at 57.9 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at NOK 193.50 up to resistance at NOK 207.40.
The shares look undervalued at 11.4 times earnings, though no sector average was available for comparison. Sell-side targets cluster 13.3% above the current quote. Revenue is growing at 14.1% on a 14.3% profit margin. The 3.28% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 20.9%, a beta of 0.00 and a maximum drawdown of 26.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 6 out of 10.

Top Market Events

Bergen, 13 May 2026 Mowi had its second best first quarter ever with operational profit of EUR 221 million on...Mowi ASA MHGVY achieves a record EUR1.54 billion in revenue with significant harvest volume growth, while navigating...The Board of Mowi ASA has resolved on 12 May 2026 to make a quarterly distribution to shareholders of NOK 2.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 213.83
  • MACD momentum is positive
  • 30-day price change of +12.4%

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Trading below the 200-day average of 213.83
  • Analyst targets imply +13.3% versus the current price
  • MACD momentum is positive

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Analyst targets imply +13.3% versus the current price
  • Revenue growth of +14.1%
  • P/E ratio of 11.4

Key Metrics & Analysis

Financial Health

Revenue Growth14.10%
Profit Margin14.33%
P/E Ratio11.4
ROE19.49%
ROA5.46%
Debt/Equity75.01
P/B Ratio2.2
Op. Cash FlowNOK859.7M
Free Cash FlowNOK110.7M

Technical Analysis

TrendNeutral
RSI57.9
SupportNOK 193.50
ResistanceNOK 207.40
MA 20NOK 200.34
MA 50NOK 194.42
MA 200NOK 213.83
MACDBullish
VolumeIncreasing
Fear & Greed Index95.27

Valuation

Target PriceNOK 230.15
Upside/Downside13.26%
GradeUndervalued
TypeValue
Dividend Yield3.28%

Risk Assessment

Beta0.00
Volatility20.88%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.